Does Liletta (levonorgestrel intrauterine system) cause emotional instability such as increased tearfulness?

Does Liletta Cause Emotional Instability Like Crying Easily?

Yes, Liletta can cause mood changes including emotional instability, anxiety, and depression as recognized side effects, though the evidence on their frequency and severity is mixed.

FDA-Recognized Mood-Related Side Effects

The FDA-approved labeling for Liletta explicitly lists several mood-related adverse reactions 1:

• Mood changes occurred in 6.5% of users in clinical trials 1
• Anxiety occurred in 9.6% of users 1
• Depression occurred in 9.1% of users 1
• Mood swings were reported as a reason for discontinuation in 0.8% of users 1

These are documented as common side effects occurring in ≥5% of participants in the Phase 3 clinical study 1.

Emerging Research Evidence on Emotional Reactivity

Recent neurobiological research provides mechanistic insight into how levonorgestrel IUDs may affect emotional processing:

• A 2024 study found that IUD users showed altered preconscious emotional processing, with higher negative amplitude of frontal N2 brain waves during emotion regulation tasks compared to naturally cycling women and oral contraceptive users 2
• This altered brain response was most pronounced during emotional up-regulation tasks, suggesting IUD use may be linked to changes in how the brain processes emotional stimuli 2
• The same study found testosterone levels correlated positively with these altered emotional processing patterns in IUD users 2

Stress Response Amplification

The levonorgestrel IUD appears to have systemic effects beyond local intrauterine action:

• A 2017 study demonstrated that LNG-IUD users had an exaggerated cortisol response to stress (24.95 nmol/L increase) compared to oral contraceptive users (3.27 nmol/L) and naturally cycling women (10.85 nmol/L) 3
• LNG-IUD users also showed elevated heart rate during stress testing and chronically elevated hair cortisol levels, indicating long-term stress system sensitization 3
• These findings suggest the LNG-IUD induces centrally-mediated sensitization of both autonomic and hypothalamic-pituitary-adrenal axis responsivity 3

Systematic Review Findings

A 2023 systematic review examining psychiatric symptoms associated with levonorgestrel IUDs found 4:

• Ten studies showed increased depressive symptoms with LNG-IUD use 4
• One study reported increased anxiety 4
• One study showed increased risk of suicidal thoughts 4
• The review concluded that despite unreliable data, many studies report psychiatric symptoms, predominantly depression 4

Contradictory Evidence on Quality of Life

Some older studies suggest neutral or positive effects:

• A 2014 study found depression scores did not increase significantly over 6 months in women using LNG-IUS for menorrhagia treatment 5
• A 2008 study reported that LNG-IUS users had higher quality of life parameters, particularly in emotional well-being, compared to other IUD users 6

However, these studies focused on women using the device for heavy bleeding treatment rather than contraception alone, which may represent a different risk-benefit profile.

Clinical Management Approach

Patient autonomy is paramount - the CDC explicitly states that patient request alone is sufficient justification for IUD removal, with no minimum threshold of side effect severity required 7. Key management principles include:

• Provide counseling about potential mood changes before insertion so patients can make informed decisions 4
• Reassure patients they may contact their provider at any time to discuss side effects 7
• Remove the device immediately if the patient requests it due to emotional symptoms, regardless of provider assessment of severity 7
• Offer counseling on alternative contraceptive methods with different hormonal profiles, such as copper IUD (hormone-free) or combined estrogen-progestin methods 7

Important Caveats

• The emotional side effects appear to have a neurobiological basis involving altered stress response and emotional processing, not just subjective complaints 2, 3
• Individual susceptibility varies widely - while mood changes affect 6-10% of users in clinical trials, many women tolerate the device well 1
• Symptoms like increased tearfulness would fall under the "mood changes" category recognized by the FDA 1
• Healthcare providers should be aware that the LNG-IUD may have systemic effects despite being marketed as having "local" action 3